CLGN (CollPlant Biotechnologies Ltd Ordinary Shares) Stock Analysis - SEC Filings

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLGN trades at $0.45 with a market cap of $6.27M and a P/E ratio of 0.00. CLGN moved +0.00% today. Year to date, CLGN is -68.75%; over the trailing twelve months it is -77.27%. Its 52-week range spans $0.27 to $5.00. Rallies surfaces CLGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CLGN SEC filings?

Rallies organizes CLGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CLGN Key Metrics

Key financial metrics for CLGN
MetricValue
Price$0.45
Market Cap$6.27M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.00
52-Week Low$0.27
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest CLGN News

CLGN Analyst Consensus

CLGN analyst coverage data. Average price target: $0.00.

Common questions about CLGN

Where can I find CLGN SEC filings?
Rallies organizes CLGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CLGN 10-K and 10-Q filings?
Rallies organizes CLGN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CLGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLGN. It does not provide personalized investment advice.
CLGN

CLGN